AML Archives - Page 2 of 4 - Together4Cancer Compass

Patients

HCPs

Home

Categories

Menin inhibitors as targeted therapy in KMT2A-Rearranged acute leukemia: A comprehensive review of current advances and therapeutic implications.

Post category:Hematologic Cancers
Reading time:2 mins read

This publication reviews the emerging role of menin inhibition as a targeted strategy for acute leukemias characterized...

Continue Reading

Optimizing lower intensity triplet therapy in acute myeloid leukemia: a practical guide.

Post category:Hematologic Cancers
Reading time:1 min read

This publication reviews the emerging use of frontline triplet therapies combining venetoclax-based doublets (azacitidin...

Continue Reading

JAK inhibitor selection in challenging scenarios of myelofibrosis: a review.

Post category:Hematologic Cancers
Reading time:1 min read

This publication reviews the current landscape of JAK inhibitors in the treatment of myelofibrosis, a myeloproliferative...

Continue Reading

Comparison of outcomes of BuCy versus BuCyMel as preparation for allogeneic HSCT in infants with acute myeloid leukemia in first complete remission: a multicenter study from the EBMT PDWP.

Post category:Hematologic Cancers
Reading time:1 min read

This international registry-based study by the EBMT evaluated conditioning regimens in children under 2 years undergoing...

Continue Reading

Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients.

Post category:Hematologic Cancers
Reading time:1 min read

This study evaluated the prognostic impact of myelodysplasia-related (MR) gene mutations in 4,978 intensively treated ac...

Continue Reading

Racial disparities in clonal hematopoiesis and their impact on hematologic malignancies.

Post category:Hematologic Cancers
Reading time:1 min read

This study analyzed clonal hematopoiesis of indeterminate potential (CHIP) and its progression to hematologic malignanci...

Continue Reading